NCT06715631

Brief Summary

The goal of this interventional, national, prospective, open and monocentric study is to demonstrate that a personal exoskeleton can be used by the intended users without serious use errors or problems, for the intended uses and under the expected use conditions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 20, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

November 18, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 4, 2024

Completed
Last Updated

December 4, 2024

Status Verified

December 1, 2024

Enrollment Period

2 months

First QC Date

November 18, 2024

Last Update Submit

December 3, 2024

Conditions

Keywords

Spinal Cord InjuriesRoboticsCommunity useHands-free exoskeletonOverground exoskeletonWalkingSelf-balancing

Outcome Measures

Primary Outcomes (1)

  • SCI user and companion performance when carrying out tasks that are critical tasks

    The acceptance criterion for this test is 100% of the trained SCI users and trained companions are able to perform each of the critical task successfully during a simulated-use test.

    At session 6, after an average of 7.5 hours of training.

Secondary Outcomes (4)

  • Use errors, close calls, and use difficulties

    At session 6, after an average of 7.5 hours of training.

  • SCI user and companion general performance when carrying non-critical tasks

    At session 6, after an average of 7.5 hours of training.

  • Readability and clarity of Instructions for Use (IFU)

    At session 5, after an average of 6 hours of training.

  • SCI user and companion opinion on the accompanying documents and training

    At session 6, after an average of 7.5 hours of training.

Other Outcomes (6)

  • SCI user and companion satisfaction and comfort

    At session 6, after an average of 7.5 hours of training.

  • Usability of donning and doffing

    At session 6, after an average of 7.5 hours of training.

  • Functional test with the exoskeleton

    At session 6, after an average of 7.5 hours of training.

  • +3 more other outcomes

Study Arms (1)

Hands-free exoskeleton

EXPERIMENTAL
Device: Hands-free exoskeleton

Interventions

Before the simulated-use test, the SCI user and his/her companion must attend five training sessions provided by a Wandercraft certified trainer. Training will be composed by a theoretical part including presentation and description of the personal exoskeleton and its use modes and a hands-on practice. Each session lasts between 1 to 2 hours, varying according to the user's learning pace and tolerance. The training program is representative of the intended training for the end product.

Hands-free exoskeleton

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any gender, age 18 years old or older.
  • Motor complete or incomplete SCI with a clinical presentation of a neurological level at or above T6.
  • Has been released from acute inpatient care following their SCI.
  • Able and willing to attend 6 one-to-two-hour sessions of training.
  • Able to read, understand, and provide informed consent.
  • Patients affiliated to a social security system.

You may not qualify if:

  • Any neurological injury other than spinal cord injury (SCI), except where such injury does not result in physical disability
  • Progressive condition that would be expected to result in changing neurological status.
  • Severe concurrent medical disease, illness or condition judged to be contraindicated by the site physician.
  • Individual with history of osteoporotic fracture and / or pathology or treatment causing secondary osteoporosis.
  • Untreatable severe spasticity judged to be contraindicated by the site physician.
  • Untreated/uncontrolled hypertension as judged to be contraindicated by the site physician.
  • Unresolved orthostatic hypotension as judged to be contraindicated by the site physician.
  • History of uncontrolled autonomic dysreflexia.
  • Presence of colostomy and/or urostomy.
  • Ventilator use at the time of exoskeleton use.
  • Presence of life supporting device (e.g., pacemaker).
  • Open or unhealed skin pressure sores, abrasions, or bruises at any of the contact points of the exoskeleton.
  • Morphological contraindications to the use of the device.
  • Uncorrectable leg length discrepancy over 2 cm (about 0.79 in) when using additional correction tools.
  • Individuals with functional and/or cognitive impairments that prevent them from effectively operating the device using a hand control interface.
  • +13 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wandercraft

Paris, 75004, France

Location

MeSH Terms

Conditions

Spinal Cord InjuriesQuadriplegiaParaplegia

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Rebecca Sauvagnac, MD

    Wandercraft

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2024

First Posted

December 4, 2024

Study Start

August 20, 2024

Primary Completion

October 31, 2024

Study Completion

October 31, 2024

Last Updated

December 4, 2024

Record last verified: 2024-12

Locations